Dr. Kinjal Shankar Majumdar

Assistant Professor

Department of Surgical Oncology


    Assistant Professor

    Department of Surgical Oncology

    Kasturba Medical College, Manipal

    MAHE Manipal


Degree Specialisation Institute Year of passing
MCh Head Neck Surgery and Oncology All India Institute of Medical Sciences Rishikesh August 2022
MS ENT Nilratan Sircar Medical College August 2016
MBBS North Bengal Medical College March 2011


Institution / Organisation Designation Role Tenure
Kasturba Medical College, Manipal Assistant Professor Surgical Oncology October 2022 - present
All India Institute of Medical Sciences Rishikesh Senior Resident - Academic Head Neck Surgery and Oncology August 2019 - August 2022
Surgical Oncology Junior Consultant Surgical Oncology September 2018 - August 2019
HCG Cancer Centre, Bengaluru Clinical Fellow - RGUHS Head and Neck Surgical Oncology January 2017 - July 2018
Asian Institute of Oncology, Mumbai Surgical Registrar Surgical Oncology September 2016 - December 2019
Nilratan Sircar Medical College, Kolkata Junior Resident - Academic Otorhinolaryngology and Head Neck Surgery August 2013 - August 2016
North Bengal Medical College, Darjeeling Junior Resident - Non-academic General Surgery March 2011 - March 2012


Principal investigator-Aneel Bhangu Co-Investigator-CovidSurg Collaborative

Funding Agencies -NIHR Global Research Unit on Global Surgery

An international multicentric collaborative cohort study with more than 250 participating institutions globally. More than 25 publications till date. 3 publications include myself as an author. 1-year follow-up study completed data accrual. 2-year follow-up study is undergoing.

Assessment of Tumor Infiltrating Lymphocytes, Tumor Associated Macrophages and Natural Killer cells as prognostic biomarkers in Oral Squamous Cell Carcinoma

Principal Investigator-Rajkumar KS Co-Investigator-Kinjal Shankar Majumdar; Ashok Singh; Dharmaram Poonia

Funding Agencies-All India Institute of Medical Sciences Rishikesh

An observational prospective single centre study with an aim to evaluate the prognostic value of tumour infiltrating lymphocytes (TILs), tumour associated macrophages (TAMs) and natural killer (NK) cells in oral squamous cell carcinoma (OSCC). The trial is registered under CTRI. It has completed its targeted accrual of 111 participants. Data analysis of phase-1 is underway. 2-year follow-up data accrual is due to be completed in October 2023.


Area of Interest

Head and neck oncology; Thyroid neoplasm; Salivary gland neoplasm; Reconstruction for head and neck surgery

Area of Expertise

Head and neck cancer; Surgery

Area of Research

Head and neck oncology; Clinical and Basic

Professional Affiliations & Contributions

Life membership of American Society of Clinical Oncology, Indian Association of Surgical Oncology, Foundation of Head and Neck Oncology, Indian Society of Oncology